Sorted By Test Name - Mayo Medical Laboratories

HIPA
9756
FHISP
57275
FHISU
57207
adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype. J Neurol Neurosurg
Psychiatry 2010;81(9):968-972 2. Vallance H, Morris TJ, Coulter-Mackie M, et al: Common HEXB
polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs
disease carrier identification. Mol Genet Metab 2006 Feb;87(2):122-127 3. Kaback MM: Hexosaminidase
A Deficiency. Available from www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=tay-sachs
Reviewed May 19, 2006 4. Neudorfer O, Pastores GM, Zeng BJ, et al: Late-onset Tay-Sachs disease:
phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 2005
Feb;7(2):119-123 5. Sutton VR: Tay-Sachs disease screening and counseling families at risk for metabolic
disease. Obstet Gynecol Clin North Am 2002 Jun;29(2):287-296 6. D'Souza G, McCann CL, Hedrick J, et
al: Tay-Sachs disease carrier screening: a 21-year experience. Genet Test 2000;4(3):257-263
Hippuric Acid, Urine
Reference Values:
Reporting limit determined each analysis
Creatinine:
U.S. Population (10th – 90th percentiles, median)
All participants:
335 - 2370 mg/L, median: 1180 (n=22,245)
Males:
495 - 2540 mg/L, median: 1370 (n=10,610)
Females:
273 - 2170 mg/L, median 994 (n=11,635)
Hippuric Acid (g/L)
Synonym(s): Hippurate; n-Benzoylglycine
Normal in an unexposed population up to 1.6 g Hippuric Acid/L urine.
Hippuric Acid (Creatinine corrected) (g/g Creat)
Synonym(s): Hippurate; n-Benzoylglycine
Biological Exposure Index (ACGIH) for monitoring
exposure to Toluene:
1.6 g Hippuric Acid/g Creatinine measured in an end of shift specimen.
Specific Gravity Confirmation
Physiologic range: 1.010-1.030.
Test Performed by: NMS Labs
3701 Welsh Road
P.O. Box 433A
Willow Grove, PA 19090-0437
Histamine Plasma
Reference Values:
Reference Range: